A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 11, 1999, Pages 2701-2707

  Carr, Molly C ^a,b   Hokanson, John E ^a   Deeb, Samir S ^b   Purnell, Jonathan Q ^a   Mitchell, Ellen S ^a   Brunzell, John D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol; LIPC; Lipoprotein; Triglyceride; Visceral obesity

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE;

ADULT; ALLELE; ARTICLE; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL ANALYSIS;

EID: 0032743295     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.11.2701     Document Type: Article

References (57)

1. Jansen H, van T-A, Hulsmann WC. On the metabolic function of heparin-releasable liver lipase. Biochem Biophys Res Commun. 1980;92:53-59.
2. Jensen GL, Daggy B, Bensadoun A. Triacylglycerol lipase, monoacylglycerol lipase and phospholipase activities of highly purified rat hepatic lipase. Biochim Biophys Acta. 1982;710:464-470.
3. Krapp A, Ahle S, Kersting S, Hua Y, Kneser K, Nielsen M, Gliemann J, Beisiegel U. Hepatic. lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). J Lipid Res, 1996;37:926-936.
4. Komaromy M, Azhar S, Cooper AD. Chinese hamster ovary cells expressing a cell surface-anchored. form of hepatic lipase. Characterization of low density lipoprotein and chylomicron remnant uptake and selective uptake of high density lipoprotein-cholesteryl ester. J Biol Chem. 1996;271:16906-16914.
5. Santamarina F-S, Haudenschild C, Amar M. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol. 1998;9:211-219.
6. Sanan DA, Fan J, Bensadoun A, Taylor JM. Hepatic lipase is abundant on both hepatocyte arid endothelial cell surfaces in the liver. J Lipid Res. 1997;38:1002-1013.
7. Cai SJ, Wong DM,. Chen SH, Chan L. Structure of the human hepatic triglyceride lipase gene. Biochemistry. 1989;28:8966-8971.
8. Ameis D, Stahnke G, Kobayashi J, McLean J, Lee G, Buscher M, Schotz MC, Will H. Isolation and characterization of the human hepatic lipase gene. J Biol Chem. 1990;265:6552-6555.
9. Kuusi T, Saarinen P, Nikkila EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 1980;36:589-593.
10. Kinnunen P, Virtanen J, Vainio P. Lipoprotein lipase and hepatic endothelial lipase: their roles in plasma metabolism. Atheroscler Rev. 1983;11:65-105.
11. Ji ZS, Dichek HL, Miranda RD, Mahley RW, Ji ZS, Dichek HL, Miranda RD, Mahley RW. Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J Biol Chem. 1997;272:31285-31292.
12. Marques V-P, Az'ema C, Collet X, Vieu C, Chap H, Perret B, Marques V-P, Az'ema C, Collet X, Vieu C. Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liven a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res. 1994;35:373-384.
13. Shafi S, Brady SE, Bensadoun A, Havel RJ. Role of hepatic lipase in the uptake and processing of chylomicron remnants in rat liver. J Lipid Res. 1994;35:709-720.
14. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb. 1993;13:147-153.
15. Austin M, Breslow J, Hennekens C, Buring J, Willett W, Krauss R. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917-1921.
16. Crouse J, Parks J, Schey H, Kahl F. Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 1985;26:566-574.
17. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, Wilson PW, Schaefer EJ. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb. 1992;12:187-195.
18. Coresh J, Kwiterovich PJ, Smith H, Bachorik P. Association of plasma triglyceride and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993;34:1687-1697.
19. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994;106:241-253.
20. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62:707-714.
21. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975;1:16-19.
22. Schieken RM. Effect of exercise on lipids. Ann N Y Acad Sci. 1991;623:269-274.
23. Sutherland WH, Temple WA, Nye ER, Herbison GP. Adiposity, lipids, alcohol consumption, smoking, and gender. Am J Clin Nutr. 1980;33:2581-2587.
24. Berchtold P, Berger M, Jorgens V, Daweke C, Chantelau E, Gries FA, Zimmermann H. Cardiovascular risk factors and HDL-cholesterol levels in obesity. Int J Obesity. 1981;5:1-10.
25. Steinmetz J, Boerwinkle E, Gueguen R, Visvikis S, Henny J, Siest G. Multivariate genetic analysis of high density lipoprotein particles. Atherosclerosis. 1992;92:219-227.
26. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R: Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest. 1994;94:2377-2384.
27. Despres JP, Ferland M, Moorjani S, Nadeau A, Tremblay A, Lupien PJ, Theriault G, Bouchard C. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 1989;9:485-492.
28. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res. 1998;39:228-232.
29. 2 cholesterol. Arterioscler Thromb Vase Biol. 1998;18:1723-1729.
30. Colvin PL Jr, Auerbach BJ, Case LD, Hazzard WR, Applebaum-Bowden D. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women. Metab Clin Exp. 1991;40:1052-1056.
31. Applebaum DM, Goldberg AP, Pykalisto OJ, Brunzell JD, Hazzard WR. Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J Clin Invest. 1977;59:601-608.
32. Tikkanen MJ, Kuusi T, Vartiainen E, Nikkila EA. Treatment of postmenopausal hypercholesterolaemia with estradiol. Acta Obstet Gynecol Scand Suppl. 1979;88:83-88.
33. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase. (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci USA. 1997;94:4532-4537.
34. Lemieux S, Prudhomme D, Bouchard C, Tremblay A, Despres JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr. 1993;58:463-467.
35. Wakatsuki A, Sagara Y. Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol. 1995;85:523-528.
36. Bjorkelund C, Lissner L, Andersson S, Lapidus L, Bengtsson C. Reproductive history in relation to relative weight and fat distribution, Int J Obes Relat Metab Disord. 1996;20:213-219.
37. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med. 1995;123:673-675.
38. Mitchell ES, Woods NF. Symptom experiences of midlife women: observations from the Seattle Midlife Women's Health Study. Maturitas. 1996;25:1-10.
39. Rifkind BM, Segal P. Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia, JAMA. 1983;250:1869-1872.
40. Austin M, King M-C, Vranizan K, Krauss RM. The atherogenic lipoprotein phenotype (ALP): a proposed genetic marker for coronary heart disease risk. Circulation. 1990;82:495-506.
41. Capell WH, Zambon A, Austin MA, Brunzell JD, Hokanson JE. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. Arterioscler Thromb Vase Biol. 1996;16:1040-1046.
42. Brown G, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan C, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Regression of coronary artery disease as a result of intensive lipid-lowering therapy, in men with high levels of apolipoprotein B [see comments]. N Engl J Med., 1990;323:1289-1298.
43. Zaharko DS, Beck LV. Studies of a simplified plasma insulin immunoassaay using cellulose powder. Diabetes. 1968;17:444-459.
44. Iverius P, Brunzell J. Human adipose tissue lipoprotein lipase: changes with feeding in relation to postheparin plasma enzyme. Am J Physiol. 1985;249:326-334.
45. Hokanson J, Austin M, Brunzell J. Measurement and clinical significance of low-density lipoprotein subclasses. In: Rifai N, Warnick G, Dominiczak M, eds. Handbook of Lipoprotein Testing. Vol 1. Washington, DC: AACC Press; 1997:267-282.
46. Chung BH, Wilkinson T, Geer JC, Segrest JP. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res. 1980;21:284-291.
47. Purnell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW, Brunzell JD. Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial. Diabetes. 1995;44:1218-1226.
48. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analysis of beta-like globin genes. Hemoglobin. 1982;6:27-36.
49. Shuman WP, Morris LL, Leonetti DL, Wahl PW, Moceri VM; Moss AA, Fujimoto WY. Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radial. 1986;21:483-487.
50. Riggs DS. Substrate-Enzyme and Drug Receptor Interactions. The Mathematical Approach to Physiological roblems. Baltimore, MD: MIT press; 1963;272-298.
51. Brunzell JD, Hazzard WR, Porte D Jr, Bierman EL. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest. 1973;52:1578-1585.
52. Dowd J, Riggs D. A comparison of estimates of Michaelis-Menton kinetic constants from various linear transformations. J Biol Chem. 1965;240:863-869.
53. Jansen H, Verhoeven AJ, Weeks L, Kastelein JJ, Halley DJ, van den Ouweland A, Jukema JW, Seidell JC, Birkenhager JC. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vase Biol. 1997;17:2837-2842.
54. Tahvanainen E, Syvanne M, Frick MH, Murtomaki-Repo S, Antikainen M, Kesaniemi YA, Kauma H, Pasternak A, Taskinen MR, Ehnholm C. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. J Clin Invest. 1998;101:956-960.
55. Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966;34:679-697.
56. Williamson DF. Descriptive epidemiology of body weight and weight change in U. S. adults. Ann Intern Med. 1993;119:646-649.
57. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, Cohen JC. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res. 1998;39:1127-1130.